SCHEMBL29838942

SCHEMBL29838942

CCOC(=O)c1nn(-c2ccc(Cl)cc2)c(-c2ccccc2)c1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
NPSR1 Q6W5P4 3/20 0.60
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
CYP19A1 P11511 2/20 0.55
KMT2A Q03164 1/20 0.53
KDM4E B2RXH2 3/20 0.53
CA4 P22748 1/20 0.53
CA9 Q16790 1/20 0.53
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
HPGD P15428 1/20 0.52
HSD17B10 Q99714 1/20 0.52
GABRA2 P47869 1/20 0.51
GABRB2 P47870 1/20 0.51
CNR1 P21554 1/20 0.51
CHEK1 O14757 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187519 0.94 CA1 (0.58) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL2919412 0.91 ALDH1A1 (0.73) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL277032 0.85 KDM4E (0.51) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL4872470 0.85 GABRA2 (0.59) CA1CA2KDM4ECA4CA9
SCHEMBL276776 0.85 CNR1 (0.57) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL29838955 0.85 CYP1A2 (0.57) CYP2C9CYP2C19CA1CA2KDM4E
SCHEMBL18353617 0.84 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL29838929 0.84 KDM4E (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL700719 0.84 CNR1 (0.58) CYP19A1CNR1
SCHEMBL327857 0.83 CNR1 (0.53) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022164239-A1 PYRAZOLE-CARBOXAMIDE DERIVATIVE COMPOUND AND USE THEREOF 주식회사 파미노젠 2022-08-04 WO disclosed